Selank
Approved (Russia/Ukraine)Selank (TP-7)
- Category
- Cognitive & Neuroprotection
- Aliases
- TP-7, Selanc
- Administration
- Intranasal spray, Subcutaneous injection
Overview
Anxiolytic and nootropic heptapeptide. Reduces anxiety without sedation or dependence while increasing BDNF and modulating multiple neurotransmitter systems.
Treatments studied
Treatment categories
Anxiety disorders
Modulates GABA-A receptor activity to reduce anxiety without the sedation typical of benzodiazepines.
Cognitive decline
Raises BDNF levels, supporting the growth and maintenance of neural connections.
Depression
Regulates serotonin and dopamine metabolism, neurotransmitter systems closely tied to mood regulation.
Immune dysregulation
Modulates cytokine expression, helping balance an overactive or underactive immune response.
PTSD
Its anxiolytic effect without sedation or dependence makes it a research candidate for trauma-related anxiety.